Wholesalers’ Q1 Earnings Remain Positive, Medical Fee Cut Rule Seen to Boost Accuracy of Financial Results in Sept.

Japan’s four leading drug wholesalers have announced their earnings for the April-June first quarter of FY2014. All four except Suzuken reported double-digit growth in operating profit from their core ethical drug wholesale businesses, even though their sales fell as demand...read more